Also trades as: RKT.L (LSE) · $vol 159M · 3RB.DE (XETRA) · $vol 0M · RBGPF (OTC) · $vol 0M · RB.SW (SIX) · $vol 0M
RBGLY OTC
Reckitt Benckiser Group plc
1W: -1.9%
1M: +5.1%
3M: +3.1%
YTD: -13.7%
1Y: -9.5%
3Y: -3.8%
5Y: -13.5%
$13.82
+0.37 (+2.75%)
Weekly Expected Move ±4.4%
$12
$13
$13
$14
$14
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$43.9B
52W Range12.02-17.8
Volume185,340
Avg Volume848,403
Beta0.25
Dividend$1.21
Analyst Ratings
Company Info
CEOKris Licht
Employees38,100
SectorConsumer Defensive
IndustryHousehold & Personal Products
IPO Date2008-10-15
Websitereckitt.com
Turner House
Slough, BR SL1 3UH
GB
Slough, BR SL1 3UH
GB
44 17 5321 7800
About Reckitt Benckiser Group plc
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.
Latest News
Danone CEO says no interest in purchasing Reckitt's Mead Johnson unit
Missouri appeals court upholds $495M ruling against Abbott in baby formula case
FDA says largest ever baby formula probe found U.S. supplies are safe
New Strong Sell Stocks for April 10th
Most sold large, mega-cap consumer staples amid U.S.-Iran tensions
Recent Insider Trades
No insider trades found